Basepoint Wealth LLC Bristol Myers Squibb CO Transaction History

Basepoint Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Oct 16, 2025	SELL	$44.12 - $59.6 $176,656 - $238,638	-4,004 Closed	0 $0
Q1 2025 Oct 16, 2025	BUY	$53.9 - $63.11 $1,940 - $2,271	36 Added 0.91%	4,004 $244 Million
Q4 2024 Oct 16, 2025	BUY	$51.92 - $59.94 $206,018 - $237,841	3,968 New	3,968 $224 Million
Q3 2023 Oct 16, 2025	SELL	$57.89 - $64.73 $3,704 - $4,142	-64 Reduced 1.55%	4,060 $236 Million
Q2 2023 Oct 15, 2025	BUY	$63.71 - $70.74 $3,249 - $3,607	51 Added 1.25%	4,124 $264 Million

Q1 2023 Oct 10, 2025	BUY	$65.71 - $74.53 $394 - $447	6 Added 0.15%	4,073 $282 Million
Q4 2022 Oct 08, 2025	BUY	$68.48 - $81.09 $1,301 - $1,540	19 Added 0.47%	4,067 $293 Million
Q3 2022 Oct 08, 2025	BUY	$0.13 - $76.84 $2 - $1,459	19 Added 0.47%	4,048 $288 Million
Q2 2022 Oct 08, 2025	SELL	$72.62 - $79.98 $4,429 - $4,878	-61 Reduced 1.49%	4,029 $310 Million
Q1 2022 Oct 08, 2025	SELL	$61.48 - $73.72 $7,992 - $9,583	-130 Reduced 3.08%	4,090 $299 Million
Q4 2021 Oct 08, 2025	BUY	$53.63 - $62.52 $226,318 - $263,834	4,220 New	4,220 $263 Million

2,680

1.58B

28M

28.4M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Basepoint Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Basepoint Wealth LLC with notifications on news.